1st Pharmaron Symposium in DMPK and Biology Was Held on May 30, 2015

BEIJING – May 30, 2015. Pharmaron  held the 1st Pharmaron Symposium in DMPK & Biology. DMPK and biology are two critical components for drug discovery and development. This First International Symposium aimed to bring together highly sought–after speakers from all over the world to speak at Pharmaron Beijing. At this significant event, leaders from both academia and biopharmaceutical industry presented advances that showcase how DMPK and biology have interacted with each other, which, in turn, has fundamentally reshaped the modern drug R&D process. The Symposium also served as a training platform to strengthen Pharmaron’s integrated R&D abilities, gained additional insight about the development of the industry, and deepened understanding of DMPK and Biology.

Featured Speakers

Dr. Jonathan Huw Connick   Dr. David C. Evans
Executive Director, Research Science at Merck  
Vice President, Head Global Pharmacokinetics, 
Dynamics & Metabloism, Janssen R&D, Johnson & Johnson
USA and MSD China   USA
Dr. Vincent Jaquet   Dr. Barry C. Jones
University of Geneva, Rue de Fribourg 5, 1201 Geneve  
Senior Principal Scientist, DMPK, Astrazeneca
Dr. Yue Ma   Prof. Jufeng Wang
Institute of Biophysics, Chinese Academy of Sciences   Director National Center for Safety Evaluation of Drugs, National Institutes for ood and Drug Control
China   China